This degree of weight loss is far greater than what was seen with earlier-generation anti-obesity medications and is approaching procedural and surgical level results, says Christopher McGowan, MD , obesity medicine specialist and founder of True You Weight Loss
Mazdutide (Innovent's IBI362, licensed from Lilly), another GLP-1/glucagon dual, read out ~18.5% weight loss on its 9 mg arm in GLORY-2 - on par with semaglutide's 2.4 mg weekly ceiling, in a population with a ceiling for semaglutide of roughly 15%
Tasteless, expensive, and total bunk." Another reviewer mentioned trying the drops for four weeks and experiencing only a slight decrease in appetite with no meaningful weight loss
Sinclair, when he first arrived as a young postdoctoral student in Dr
This helps increase the medications effects, allowing for a faster weight loss